Obviously IMU need a facility that can reliably produce this oncolytic virus as part of “a true end-to-end solution”. But there is more we can draw from the terms ...
It states... “to support its future drug product supply needs that require an ample drug supply for extended later phase clinical trials, it selected ABL, a CDMO that can provide added expertise and scale” ... the agreement is for a five-year term, noting that the delivery of the first clinical batch of VAXINIA is anticipated within 12 months”.
This certainly shows a level of confidence doesn’t it? Five years! And ... covering off for ‘later phase clinical trials’.
You would be thinking that the IMU team are seeing something ‘interesting’ in the trials to be making these statements and signing to this level of agreement.
Just my opinion but CF33 just looks more and more ‘interesting’ doesn’t it?
Obviously IMU need a facility that can reliably produce this...
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |